Wilkus-Adamczyk K, Brodaczewska K, Kieda C
Sci Rep. 2024; 14(1):31747.
PMID: 39738367
PMC: 11686244.
DOI: 10.1038/s41598-024-82638-7.
Fan S, Guo J, Nie H, Xiong H, Xia Y
Genes Chromosomes Cancer. 2024; 63(11):e70008.
PMID: 39584783
PMC: 11587691.
DOI: 10.1002/gcc.70008.
Manoj A, Ahmad M, Kumar M, Quayoom S, Prasad G, Kumar D
Indian J Med Res. 2024; 160(2):236-245.
PMID: 39513205
PMC: 11544578.
DOI: 10.25259/ijmr_2274_23.
Wang Q, Yang H
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459035
PMC: 11510623.
DOI: 10.3390/ph17101396.
Chang M, Chan C, Brune J, Manicone A, Bomsztyk K, Frevert C
Am J Physiol Cell Physiol. 2024; 327(5):C1274-C1288.
PMID: 39400584
PMC: 11559644.
DOI: 10.1152/ajpcell.00174.2024.
GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner.
Rivas V, Gonzalez-Munoz T, Albitre A, Lafarga V, Delgado-Arevalo C, Mayor Jr F
Cell Death Discov. 2024; 10(1):385.
PMID: 39198399
PMC: 11358448.
DOI: 10.1038/s41420-024-02143-8.
Regulation of Versican Expression in Macrophages is Mediated by Canonical Type I Interferon Signaling via ISGF3.
Chang M, Chan C, Brune J, Manicone A, Bomsztyk K, Frevert C
bioRxiv. 2024; .
PMID: 38559011
PMC: 10980001.
DOI: 10.1101/2024.03.14.585097.
The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B, Kaltenegger H, Eck N, Glanzer D, Leithner A, Kretschmer N
Int J Mol Sci. 2023; 24(21).
PMID: 37958891
PMC: 10650664.
DOI: 10.3390/ijms242115910.
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.
Shen J, Wang Q, Mao Y, Gao W, Duan S
MedComm (2020). 2023; 4(3):e288.
PMID: 37256211
PMC: 10225743.
DOI: 10.1002/mco2.288.
PTBP1 controls intestinal epithelial regeneration through post-transcriptional regulation of gene expression.
Chembazhi U, Tung W, Hwang H, Wang Y, Lalwani A, Nguyen K
Nucleic Acids Res. 2023; 51(5):2397-2414.
PMID: 36744439
PMC: 10018364.
DOI: 10.1093/nar/gkad042.
Circular RNAs Involved in the Regulation of the Age-Related Pathways.
Wang S, Xiao F, Li J, Fan X, He Z, Yan T
Int J Mol Sci. 2022; 23(18).
PMID: 36142352
PMC: 9500598.
DOI: 10.3390/ijms231810443.
The Role of PTEN in Epithelial-Mesenchymal Transition.
Fedorova O, Parfenyev S, Daks A, Shuvalov O, Barlev N
Cancers (Basel). 2022; 14(15).
PMID: 35954450
PMC: 9367281.
DOI: 10.3390/cancers14153786.
Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
Ebrahim N, Al Saihati H, Mostafa O, Hassouna A, Abdulsamea S, Abd El Aziz M El Gebaly E
Int J Mol Sci. 2022; 23(11).
PMID: 35682646
PMC: 9181089.
DOI: 10.3390/ijms23115967.
Single-cell analysis of p53 transitional dynamics unravels stimulus- and cell type-dependent signaling output motifs.
Xie J, Zhang L, Liu B, Liang X, Shi J
BMC Biol. 2022; 20(1):85.
PMID: 35410287
PMC: 9004066.
DOI: 10.1186/s12915-022-01290-7.
The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy.
Deng J, Liu Y, Liu Y, Li W, Nie X
J Inflamm Res. 2021; 14:5273-5290.
PMID: 34703268
PMC: 8524061.
DOI: 10.2147/JIR.S334996.
Molecular mechanisms underpinning sarcomas and implications for current and future therapy.
Damerell V, Pepper M, Prince S
Signal Transduct Target Ther. 2021; 6(1):246.
PMID: 34188019
PMC: 8241855.
DOI: 10.1038/s41392-021-00647-8.
Morphological and Molecular Characterization of Proliferative Inflammatory Atrophy in Canine Prostatic Samples.
de Godoy Fernandes G, Pedrina B, de Faria Lainetti P, Kobayashi P, Mollica Govoni V, Palmieri C
Cancers (Basel). 2021; 13(8).
PMID: 33920045
PMC: 8071022.
DOI: 10.3390/cancers13081887.
Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo.
Huang H, Park S, Zhang H, Park S, Kwon W, Kim E
J Exp Clin Cancer Res. 2021; 40(1):114.
PMID: 33785035
PMC: 8010944.
DOI: 10.1186/s13046-021-01895-w.
The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme.
Maksoud S
Mol Neurobiol. 2021; 58(7):3252-3269.
PMID: 33665742
PMC: 8260465.
DOI: 10.1007/s12035-021-02339-4.
TP53 and PTEN as driver mutations in Zenker's carcinoma-a clinical presentation.
Noel Z, Hoeller S, Bihl M, Muller L
Clin Case Rep. 2020; 8(12):2791-2797.
PMID: 33363824
PMC: 7752333.
DOI: 10.1002/ccr3.3169.